Request Offer


  • ZiggyLabs, established in late 2016, is a boutique, R&D-focussed animal health company committed to winning the fight against cancer in dogs and cats.
  • Currently, our focus is on developing therapies for hemangiosarcoma (HSA), a devastating, always-fatal blood malignancy with no effective treatment to date.
  • We use a drug repositioning model, investigating existing drugs to identify their efficacy in cancer therapy.